The her2 gene is amplified in 25 to 30 percent of human primary breast cancers1, and its over-expression increases breast cancer cell (MCF-7) invasiveness and tumorigenicity2 and induces proliferative and antiapoptotic changes of human mammary epithelial cells3,4, which is a characteristic of breast cancers5. Here, ERBB2 is linked to breast carcinoma.